Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
Coller
B S
BS
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. bcoller@smtplink.mssm.edu
D000077284:Abciximab; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D001808:Blood Vessels / Q000473:pathology; D002448:Cell Adhesion / Q000187:drug effects; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000494:pharmacology / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab